[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100422044":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":28,"locations":34,"responsibleParty":184,"collaborators":11,"id":186,"slug":187,"hasResults":188,"nctId":189,"briefTitle":190,"officialTitle":191,"acronym":11,"eligibilityCriteria":192,"healthyVolunteers":188,"sex":193,"minAge":194,"maxAge":11,"enrollmentInfo":195,"targetDuration":11,"studyType":198,"phases":199,"briefSummary":201,"conditions":202,"keywords":11,"overallStatus":37,"whyStopped":11,"lastUpdateSubmitDate":204,"lastUpdatePostDateStruct":205,"startDateStruct":208,"completionDateStruct":210,"leadSponsor":212,"locationsCount":213},{"fullName":5,"class":6},"Hanmi Pharmaceutical Company Limited","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"HM15912 0.5 mg\u002Fkg, 1.0mg\u002Fkg, 1.5mg\u002Fkg Active","EXPERIMENTAL",null,[13],"Drug: HM15912 Active",{"label":15,"type":16,"description":11,"interventionNames":17},"Matching Placebo","PLACEBO_COMPARATOR",[18],"Drug: Placebo",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","HM15912 Active","Randomized, double-blind, placebo-controlled",[9],{"type":21,"name":26,"description":23,"armGroupLabels":27,"otherNames":11},"Placebo",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":11,"email":33},"Wooyoung Amy Hong","CONTACT","+82 2 410 9238","wooyoung.hong@hanmi.co.kr",[35,49,59,71,82,93,102,111,120,132,141,153,163,175],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":11},"Brigham & Women's Hospital","RECRUITING","Boston","Massachusetts","02115","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-71.05977,42.35843,{"lat":47,"lon":46},{"facility":50,"status":37,"city":51,"state":52,"zip":53,"country":41,"countryCode":42,"cosmosGeoPoint":54,"geoPoint":58,"contacts":11},"The Cleveland Clinic Foundation","Cleveland","Ohio","44195",{"type":44,"coordinates":55},[56,57],-81.69541,41.4995,{"lat":57,"lon":56},{"facility":60,"status":37,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":70,"contacts":11},"UZ Leuven","Leuven","Vlaams Brabant","3000","Belgium","BE",{"type":44,"coordinates":67},[68,69],4.70093,50.87959,{"lat":69,"lon":68},{"facility":72,"status":37,"city":73,"state":11,"zip":74,"country":75,"countryCode":76,"cosmosGeoPoint":77,"geoPoint":81,"contacts":11},"Rigshospitalet Department of Digestive Diseases, Transplantation and General Surgery Section for Intestinal Failure","Copenhagen","2100","Denmark","DK",{"type":44,"coordinates":78},[79,80],12.56553,55.67594,{"lat":80,"lon":79},{"facility":83,"status":37,"city":84,"state":84,"zip":85,"country":86,"countryCode":87,"cosmosGeoPoint":88,"geoPoint":92,"contacts":11},"Hopital Beaujon","Clichy","92110","France","FR",{"type":44,"coordinates":89},[90,91],2.30952,48.90018,{"lat":91,"lon":90},{"facility":94,"status":37,"city":95,"state":11,"zip":96,"country":86,"countryCode":87,"cosmosGeoPoint":97,"geoPoint":101,"contacts":11},"Centre Hospitalier Universitaire de Bordeaux","Bordeaux","33000",{"type":44,"coordinates":98},[99,100],-0.58046,44.84124,{"lat":100,"lon":99},{"facility":103,"status":37,"city":104,"state":11,"zip":105,"country":86,"countryCode":87,"cosmosGeoPoint":106,"geoPoint":110,"contacts":11},"Les Hospices Civils de Lyon","Lyon","69002",{"type":44,"coordinates":107},[108,109],4.84789,45.74906,{"lat":109,"lon":108},{"facility":112,"status":37,"city":113,"state":11,"zip":114,"country":86,"countryCode":87,"cosmosGeoPoint":115,"geoPoint":119,"contacts":11},"Centre Hospitalier Universitaire de Nice","Nice","06300",{"type":44,"coordinates":116},[117,118],7.26608,43.70313,{"lat":118,"lon":117},{"facility":121,"status":37,"city":122,"state":123,"zip":124,"country":125,"countryCode":126,"cosmosGeoPoint":127,"geoPoint":131,"contacts":11},"Asklepios Klinik St. Georg","Hamburg","Free and Hanseatic City of Hamburg","20099","Germany","DE",{"type":44,"coordinates":128},[129,130],9.99302,53.55073,{"lat":130,"lon":129},{"facility":133,"status":37,"city":134,"state":134,"zip":135,"country":125,"countryCode":126,"cosmosGeoPoint":136,"geoPoint":140,"contacts":11},"Universitätsklinikum Tübingen","Tübingen","72076",{"type":44,"coordinates":137},[138,139],9.05222,48.52266,{"lat":139,"lon":138},{"facility":142,"status":37,"city":143,"state":144,"zip":145,"country":146,"countryCode":147,"cosmosGeoPoint":148,"geoPoint":152,"contacts":11},"Wojewodzki Specjalistyczny Szpital im. Mikołaja Pirogowa w Łodzi","Lodz","Łódź Voivodeship","90-531","Poland","PL",{"type":44,"coordinates":149},[150,151],19.47395,51.77058,{"lat":151,"lon":150},{"facility":154,"status":37,"city":155,"state":11,"zip":156,"country":157,"countryCode":11,"cosmosGeoPoint":158,"geoPoint":162,"contacts":11},"Samsung Medical Center","Seoul","06351","South Korea",{"type":44,"coordinates":159},[160,161],126.9784,37.566,{"lat":161,"lon":160},{"facility":164,"status":37,"city":165,"state":166,"zip":167,"country":168,"countryCode":169,"cosmosGeoPoint":170,"geoPoint":174,"contacts":11},"Salford Royal Hospital","Salford","Greater Manchester","M6 8HD","United Kingdom","UK",{"type":44,"coordinates":171},[172,173],-2.29042,53.48771,{"lat":173,"lon":172},{"facility":176,"status":37,"city":177,"state":11,"zip":178,"country":168,"countryCode":169,"cosmosGeoPoint":179,"geoPoint":183,"contacts":11},"Central Middlesex Hospital","London","NW10 7NS",{"type":44,"coordinates":180},[181,182],-0.12574,51.50853,{"lat":182,"lon":181},{"type":185,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100422044","phase-2-phase-2-study-to-assess-the-safety-pk-and-pd-of-sonefpeglutide-hm15912-in-sbs-if-subjects-100422044",false,"NCT04775706","Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects","A Multicenter, Proof-of-concept, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15912 (Sonefpeglutide) in Adult Subjects With Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)","Inclusion Criteria:\n\n1. Men or women, aged 18 years of age or older with SBS resulting in intestinal failure at the time of signing the informed consent form (ICF) (or country's legal age of majority if the legal age is \\\u003C18 years)\n2. Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the ICF and in this protocol\n3. Diagnosis of SBS with the latest intestinal resection being at least 6 months prior to Screening and considered stable regarding the PN\u002FIV need. No restorative surgery planned in the study period.\n\nExclusion Criteria:\n\n1. Any history of colon cancer.\n2. History of any other cancers (except margin-free resected cutaneous basal or squamous cell carcinoma or adequately treated in situ cervical cancer) unless disease-free for at least 5 years\n3. History of alcohol or drug abuse (within 1 year of screening)","ALL","18 Years",{"count":196,"type":197},18,"ESTIMATED","INTERVENTIONAL",[200],"PHASE2","This is a randomized, double-blind, placebo-controlled, proof-of-concept (PoC), Phase 2 study to assess the safety, PK, and PD of SC administration of HM15912(sonefpeglutide) in adult subjects with SBS-associated intestinal failure (SBS-IF).",[203],"Short Bowel Syndrome","2026-04-26",{"date":206,"type":207},"2026-04-28","ACTUAL",{"date":209,"type":207},"2022-03-03",{"date":211,"type":197},"2028-05",{"name":5,"class":6},14]